That said, our experiments, in particular the CHIP assay illustrate that some of the actions of MEK-162 in corticotroph tumor cells to inhibit POMC transcription and tumor growth directly involve the actions of TR4 on corticotroph tumors. The gene discussed is NR2C2; the disease is neoplasm.